Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with early-stage prostate cancer, based on their medical records, with specific cancer severity and grade scores within certain ranges (confirm with trial site for exact values)
- People who have had their prostate surgically removed (called a radical prostatectomy), either at MSKCC or at another hospital
- People who had their prostate surgery no more than 9 months ago
- People who had at least moderate erectile function before surgery, based on scores from standard medical questionnaires or rating scales recorded in their medical records
- People who are already starting or have started a penile injection program as part of erectile rehabilitation at MSKCC, either by their own report or as recorded in their medical records
- People who, in the judgment of the trial staff, are able to communicate, understand, and complete questionnaires in English
Who may not be able to join:
- People whose surgery involved complete removal of both cavernous nerves (the nerves on both sides involved in erectile function), as documented in surgical records
- People who are currently taking, or have previously taken, hormone-suppressing therapy (called Androgen Deprivation Therapy or ADT)
- People who have any detectable PSA (a protein in the blood that can indicate prostate cancer activity) (confirm with trial site for exact details)
- People who report having a specific phobia of injections
- People who, in the judgment of the trial staff, are unable to give informed consent or complete the study sessions and assessments
- People who currently have an untreated major psychiatric condition, such as schizophrenia or major depression (those with a diagnosed major psychiatric condition would be reviewed by the study's lead researcher before a decision is made about eligibility)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rebecca Saracino, PhD, Memorial Sloan Kettering Cancer Center
Phone: 646-888-0263
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
percentages of patients having an Erectile Function Domain (EFD) total score >= 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.